Latest Articles
- How do I diagnose and treat my patient’s amiodarone-induced thyrotoxicosis?
Differentiating type 1 from type 2 amiodarone-induced thyrotoxicosis requires serologic testing, color Doppler ultrasonography, and radioisotope studies, and influences the choice of treatment.
- Acute left-sided colonic diverticulitis: A surgeon’s perspective on the ACP guidelines
The updated guidelines push for less-aggressive management of uncomplicated diverticulitis in select patients.
- Unexplained pathology is not always autoimmune
Our success in understanding well-defined autoimmune diseases may make us too willing to attribute yet-unexplained conditions to autoimmunity simply because they share symptoms.
- Serial serum lipase testing after the initial diagnostic workup for inpatients with acute pancreatitis: What is the evidence?
Beyond the initial diagnostic workup, the results of serial testing may be misleading, with the potential for adverse effects on patient care and increases in healthcare spending.
- Deadly drug rashes: Early recognition and multidisciplinary care
An illustrated review of 4 severe drug rashes. Early recognition and prompt withdrawal of the causative agent are crucial.
- Celiac disease in the ‘nonclassic’ patient
Adherence to a strict gluten-free diet is not easy, and even strict adherence does not guarantee relief of all symptoms. We need to be as certain as possible that trying the diet makes sense—and that is the real challenge.
- Measuring exhaled nitric oxide when diagnosing and managing asthma
The authors examine the role of this biomarker of airway inflammation and provide guidance for its appropriate use.
- Celiac disease: Who should I test, and how?
First-degree relatives of patients with celiac disease and patients with dermatitis herpetiformis, type 1 diabetes mellitus, and autoimmune thyroid disease are among those for whom testing is advisable.